Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…
OSIJEK, Croatia, Dec. 1, 2025 /PRNewswire/ -- Orqa, Europe's leading developer of FPV (first-person view) and unmanned aerial systems (UAS),…
HONG KONG, Nov. 29, 2025 /PRNewswire/ -- Vantage Foundation has donated HK$1 million to support the emergency response and post-disaster reconstruction…
Hanover, Germany, Nov. 22, 2025 (GLOBE NEWSWIRE) -- CHC Navigation shared a significantly positive market engagement following the successful conclusion…
Beginning in 2026, Partnership Will Elevate Flagship Race's Global Profile and Significantly Expand Access to Running Opportunities for Children ADDIS…
Strategic Infrastructure Growth Positions Vieworks at the Forefront of Global Imaging Innovation ANYANG, South Korea, Nov. 12, 2025 /PRNewswire/ --…
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The…
In a landmark move aimed at significantly enhancing its research and development capabilities, Dansy Labs Private Limited has announced the…
NEW DELHI, Oct. 9, 2025 /PRNewswire/ -- MSN Laboratories, a leading global Indian pharmaceutical company, today announced that it is…
HONG KONG, Oct. 2, 2025 /PRNewswire/ -- A landmark study conducted by The Hong Kong University of Science and Technology…